Non-viral vectors transform gene delivery for cell therapies
Discover a novel non-viral gene delivery system that could transform cell and gene therapy workflows
Discover a novel non-viral gene delivery system that could transform cell and gene therapy workflows
Discover, connect, and innovate with global scientific leaders at the virtual SelectScience Analytical Summit 2024
Find out which lab products scientists are using to advance the field and what their experiences have been
Explore the evolving role of robotics in lab automation, from repetitive tasks to dynamic workflows
New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technologies developed at the University of Sheffield
Hear from leading scientists how they are bringing the promise of customized medicine to life, and discover the key players in an industry that is shaping the future of cell and gene therapy
Global Head of Medical Affairs at Agilent Technologies offers insights into the technologies driving the field of precision oncology
Explore how a nascent method for the precise production of CAR-T cells could pave the way for the next generation of cancer assassins
Explore the cutting-edge technologies and methods driving advancements in food quality, safety, and authenticity, from streamlined quality control monitoring to automated cryogen-free analysis systems
Discover how the Wellcome Sanger Institute is helping to develop a physical atlas of all human organs
Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality
Non-targeted analysis (NTA) testing can help reveal the hidden dangers of 'forever chemicals’ following findings linking PFAS exposure to thyroid cancer
As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality
Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials
Agilent Technologies, Thermo Fisher Scientific, and Tecan among those recognized
Examine the benefits and logistics of transitioning your program from traditional site-based blood collection to remote sampling
Discover which products have earned a coveted Seal of Quality award
Visit our new Cell and Gene Therapy Accelerating Science feature to explore the remarkable achievements in the field and investigate the possibilities ahead
Learn about the pioneering work of the Columbia Stem Cell Initiative and how technological advancements are helping drive scientific breakthroughs at its Flow Cytometry Core Facility
To be in with a chance to win a $500 Amazon.com Gift Card (or equivalent currency) cast your vote for the products which have had the biggest impact on laboratory sustainability
Discover the latest webinars, methods and products in gene editing technology
Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy
In this guest editorial, discover how Capitainer® DBS cards with qDBS technology enable easy self-sampling with precision and accuracy
Experts share how commitment to bioanalytical innovation and quality has enabled success in biotherapeutic development
Casgevy™ and Lyfgenia™ approvals pave the way for personalized gene editing therapies in treating sickle cell disease